Previous close | 8.46 |
Open | 9.12 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 8.46 - 8.46 |
52-week range | 7.46 - 15.80 |
Volume | |
Avg. volume | 2,929 |
Market cap | 5.45B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 84.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 03 Jun 2021 |
1y target est | N/A |
(Bloomberg) -- Grifols SA shares dropped as investors evaluated a regulatory review of the Spanish bio-science company’s financial reports, which found “relevant deficiencies” but no major accounting mistakes.Most Read from BloombergNY Gears Up to Seize Trump Westchester Assets If Fraud Fine Is UnpaidBaltimore Wants to Sell Hundreds of Vacant Homes for $1 EachWhat Happens If Trump Can’t Post His $454 Million BondChina Scrutinizes PwC Role in $78 Billion Evergrande Fraud CaseYemen’s Houthis Tell
Europe's main stock indices were flat on Friday, but notched strong gains over the week that saw record highs from German and French shares, while investors also analysed a U.S. jobs report for clues on the global monetary policy outlook. Technology lost 1.6% after BE Semiconductor slumped 16.1% on a media report that Joint Electron Device Engineering Council lowered certain chip standards which might delay investments into hybrid bonding technology.
(Bloomberg) -- Grifols SA shares fell the most ever on Thursday after management said the Spanish plasma maker may not generate cash this year, dealing a heavier blow to the stock than last month’s attack by a short seller.Most Read from BloombergTrump Warns of Big Losses From Asset Sales During Property SlumpFed’s Preferred Inflation Metric Increases by Most in a YearStocks End Month at New Highs After Inflation Data: Markets WrapBiden Amasses Cash Lead as Trump Bleeds Money in 2024 FightThe 35